Patients with HF were also more often treated with an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, diuretic, β-blocker, and lipid-lowering agent than patients without HF (Table 1). The gene discussed is ACE; the disease is hydrops fetalis.